Molecular profiling of prostatic acinar morphogenesis identifies PDCD4 and KLF6 as tissue architecture-specific prognostic markers in prostate cancer

American Journal of Pathology

Volumn 182, Issue 2, 2013, Pages 363-374

  Li, Chi Rong ^a,b   Su, Jimmy J M ^a   Wang, Wei Yu ^a   Lee, Michael T L ^c   Wang, Ting Yun ^a   Jiang, Kuan Ying ^a   Li, Chein Feng ^d   Hsu, Jong Ming ^e   Chen, Chi Kuan ^e   Chen, Marcelo ^e   Jiang, Shih Sheng ^a   Weaver, Valerie M ^f   Tsai, Kelvin K C ^a,g  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KUN SHAN UNIVERSITY   (Taiwan)

^d Chi Mei Foundational Medical Center   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 6; MOLECULAR MARKER; PROGRAMMED CELL DEATH PROTEIN 4; PROGRAMMED DEATH 1 RECEPTOR; RNA; TRANSCRIPTOME; TUMOR MARKER; UNCLASSIFIED DRUG;

ACINAR CELL; ARTICLE; BASEMENT MEMBRANE; CANCER CLASSIFICATION; CANCER PROGNOSIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; EPITHELIUM; EPITHELIUM CELL; GENE CLUSTER; GENE EXPRESSION PROFILING; GLEASON SCORE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DIFFERENTIATION; TISSUE SPECIFICITY;

ACINAR CELLS; AGED; APOPTOSIS REGULATORY PROTEINS; CELL DIFFERENTIATION; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MIDDLE AGED; MORPHOGENESIS; ORGAN SPECIFICITY; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECURRENCE; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872702300     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.10.024     Document Type: Article

References (47)

1. A. Bill-Axelson, L. Holmberg, M. Ruutu, M. Haggman, S.O. Andersson, S. Bratell, A. Spangberg, C. Busch, S. Nordling, H. Garmo, J. Palmgren, H.O. Adami, B.J. Norlen, and J.E. Johansson Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 352 2005 1977 1984
2. C.R. Pound, A.W. Partin, M.A. Eisenberger, D.W. Chan, J.D. Pearson, and P.C. Walsh Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
3. I.P. Gorlov, J. Byun, O.Y. Gorlova, A.M. Aparicio, E. Efstathiou, and C.J. Logothetis Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data BMC Med Genomics 2 2009 48
4. I.P. Gorlov, K. Sircar, H. Zhao, S.N. Maity, N.M. Navone, O.Y. Gorlova, P. Troncoso, C.A. Pettaway, J.Y. Byun, and C.J. Logothetis Prioritizing genes associated with prostate cancer development BMC Cancer 10 2010 599
5. X. Zhang, M.V. Fournier, J.L. Ware, M.J. Bissell, A. Yacoub, and Z.E. Zehner Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo Mol Cancer Ther 8 2009 499 508
6. L. True, I. Coleman, S. Hawley, C.Y. Huang, D. Gifford, R. Coleman, T.M. Beer, E. Gelmann, M. Datta, E. Mostaghel, B. Knudsen, P. Lange, R. Vessella, D. Lin, L. Hood, and P.S. Nelson A molecular correlate to the Gleason grading system for prostate adenocarcinoma Proc Natl Acad Sci U S A 103 2006 10991 10996
7. D.F. Gleason Histologic grading of prostate cancer: a perspective Hum Pathol 23 1992 273 279
8. T.A. Stamey, J.E. McNeal, C.M. Yemoto, B.M. Sigal, and I.M. Johnstone Biological determinants of cancer progression in men with prostate cancer JAMA 281 1999 1395 1400
9. P.C. Albertsen, D.G. Fryback, B.E. Storer, T.F. Kolon, and J. Fine Long-term survival among men with conservatively treated localized prostate cancer JAMA 274 1995 626 631
10. D. Singh, P.G. Febbo, K. Ross, D.G. Jackson, J. Manola, C. Ladd, P. Tamayo, A.A. Renshaw, A.V. D'Amico, J.P. Richie, E.S. Lander, M. Loda, P.W. Kantoff, T.R. Golub, and W.R. Sellers Gene expression correlates of clinical prostate cancer behavior Cancer Cell 1 2002 203 209
11. G.V. Glinsky, A.B. Glinskii, A.J. Stephenson, R.M. Hoffman, and W.L. Gerald Gene expression profiling predicts clinical outcome of prostate cancer J Clin Invest 113 2004 913 923
12. J.K. Stratford, D.J. Bentrem, J.M. Anderson, C. Fan, K.A. Volmar, J.S. Marron, E.D. Routh, L.S. Caskey, J.C. Samuel, C.J. Der, L.B. Thorne, B.F. Calvo, H.J. Kim, M.S. Talamonti, C.A. Iacobuzio-Donahue, M.A. Hollingsworth, C.M. Perou, and J.J. Yeh A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma PLoS Med 7 2010 e1000307
13. L.J. van't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, A.T. Witteveen, G.J. Schreiber, R.M. Kerkhoven, C. Roberts, P.S. Linsley, R. Bernards, and S.H. Friend Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536
14. M.J. van de Vijver, Y.D. He, L.J. van't Veer, H. Dai, A.A. Hart, D.W. Voskuil, G.J. Schreiber, J.L. Peterse, C. Roberts, M.J. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, T. van der Velde, H. Bartelink, S. Rodenhuis, E.T. Rutgers, S.H. Friend, and R. Bernards A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 2002 1999 2009
15. S.M. Henshall, D.E. Afar, J. Hiller, L.G. Horvath, D.I. Quinn, K.K. Rasiah, K. Gish, D. Willhite, J.G. Kench, M. Gardiner-Garden, P.D. Stricker, H.I. Scher, J.J. Grygiel, D.B. Agus, D.H. Mack, and R.L. Sutherland Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse Cancer Res 63 2003 4196 4203
16. J. Lapointe, C. Li, J.P. Higgins, M. van de Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, U. Bergerheim, P. Ekman, A.M. DeMarzo, R. Tibshirani, D. Botstein, P.O. Brown, J.D. Brooks, and J.R. Pollack Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc Natl Acad Sci U S A 101 2004 811 816
17. M. Bibikova, E. Chudin, A. Arsanjani, L. Zhou, E.W. Garcia, J. Modder, M. Kostelec, D. Barker, T. Downs, J.B. Fan, and J. Wang-Rodriguez Expression signatures that correlated with Gleason score and relapse in prostate cancer Genomics 89 2007 666 672
18. C. Sotiriou, P. Wirapati, S. Loi, A. Harris, S. Fox, J. Smeds, H. Nordgren, P. Farmer, V. Praz, B. Haibe-Kains, C. Desmedt, D. Larsimont, F. Cardoso, H. Peterse, D. Nuyten, M. Buyse, M.J. Van de Vijver, J. Bergh, M. Piccart, and M. Delorenzi Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 98 2006 262 272
19. H.Y. Chang, J.B. Sneddon, A.A. Alizadeh, R. Sood, R.B. West, K. Montgomery, J.T. Chi, M. van de Rijn, D. Botstein, and P.O. Brown Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds PLoS Biol 2 2004 E7
20. M.V. Fournier, K.J. Martin, P.A. Kenny, K. Xhaja, I. Bosch, P. Yaswen, and M.J. Bissell Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer Cancer Res 66 2006 7095 7102
21. R. Liu, X. Wang, G.Y. Chen, P. Dalerba, A. Gurney, T. Hoey, G. Sherlock, J. Lewicki, K. Shedden, and M.F. Clarke The prognostic role of a gene signature from tumorigenic breast-cancer cells N Engl J Med 356 2007 217 226
22. D. Bello, M.M. Webber, H.K. Kleinman, D.D. Wartinger, and J.S. Rhim Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18 Carcinogenesis 18 1997 1215 1223
23. V.M. Weaver, O.W. Petersen, F. Wang, C.A. Larabell, P. Briand, C. Damsky, and M.J. Bissell Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies J Cell Biol 137 1997 231 245
24. G.Y. Lee, P.A. Kenny, E.H. Lee, and M.J. Bissell Three-dimensional culture models of normal and malignant breast epithelial cells Nat Methods 4 2007 359 365
25. Y. Wang, J.G. Klijn, Y. Zhang, A.M. Sieuwerts, M.P. Look, F. Yang, D. Talantov, M. Timmermans, M.E. Meijer-van Gelder, J. Yu, T. Jatkoe, E.M. Berns, D. Atkins, and J.A. Foekens Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 2005 671 679
26. M.J. Pencina, and R.B. D'Agostino Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation Stat Med 23 2004 2109 2123
27. G. Narla, A. DiFeo, S. Yao, A. Banno, E. Hod, H.L. Reeves, R.F. Qiao, O. Camacho-Vanegas, A. Levine, A. Kirschenbaum, A.M. Chan, S.L. Friedman, and J.A. Martignetti Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread Cancer Res 65 2005 5761 5768
28. A.J. Stephenson, M.W. Kattan, J.A. Eastham, Z.A. Dotan, F.J. Bianco Jr., H. Lilja, and P.T. Scardino Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition J Clin Oncol 24 2006 3973 3978
29. D.A. Budwit-Novotny, K.S. McCarty, E.B. Cox, J.T. Soper, D.G. Mutch, W.T. Creasman, J.L. Flowers, and K.S. McCarty Jr. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody Cancer Res 46 1986 5419 5425
30. M.S. Pepe The Statistical Evaluation of Medical Tests for Classification and Prediction 2003 Oxford University Press New York
31. K.M. Yamada, and E. Cukierman Modeling tissue morphogenesis and cancer in 3D Cell 130 2007 601 610
32. M.J. Bissell, A. Rizki, and I.S. Mian Tissue architecture: the ultimate regulator of breast epithelial function Curr Opin Cell Biol 15 2003 753 762
33. J. Debnath, and J.S. Brugge Modelling glandular epithelial cancers in three-dimensional cultures Nat Rev Cancer 5 2005 675 688
34. M.M. Webber, D. Bello, H.K. Kleinman, and M.P. Hoffman Acinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells Carcinogenesis 18 1997 1225 1231
35. G. Narla, K.E. Heath, H.L. Reeves, D. Li, L.E. Giono, A.C. Kimmelman, M.J. Glucksman, J. Narla, F.J. Eng, A.M. Chan, A.C. Ferrari, J.A. Martignetti, and S.L. Friedman KLF6, a candidate tumor suppressor gene mutated in prostate cancer Science 294 2001 2563 2566
36. Q. Wang, Z.X. Sun, H. Allgayer, and H.S. Yang Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells Oncogene 29 2010 128 138
37. A. DiFeo, G. Narla, O. Camacho-Vanegas, H. Nishio, S.L. Rose, R.E. Buller, S.L. Friedman, M.J. Walsh, and J.A. Martignetti E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor Oncogene 25 2006 6026 6031
38. J. Wang, R.F. Place, V. Huang, X. Wang, E.J. Noonan, C.E. Magyar, J. Huang, and L.C. Li Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration Cancer Res 70 2010 10182 10191
39. S.C. Lin, C.W. Chien, J.C. Lee, Y.C. Yeh, K.F. Hsu, Y.Y. Lai, and S.J. Tsai Suppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cells J Clin Invest 121 2011 1905 1916
40. K. Reiss, J.Y. Wang, G. Romano, X. Tu, F. Peruzzi, and R. Baserga Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells Oncogene 20 2001 490 500
41. S. Malhotra, J. Lapointe, K. Salari, J.P. Higgins, M. Ferrari, K. Montgomery, M. van de Rijn, J.D. Brooks, and J.R. Pollack A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer PLoS One 6 2011 e20293
42. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J.S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C.M. Perou, P.E. Lonning, P.O. Brown, A.L. Borresen-Dale, and D. Botstein Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 100 2003 8418 8423
43. F. Andre, and L. Pusztai Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy Nat Clin Pract Oncol 3 2006 621 632
44. N. LaRonde-LeBlanc, A.N. Santhanam, A.R. Baker, A. Wlodawer, and N.H. Colburn Structural basis for inhibition of translation by the tumor suppressor Pdcd4 Mol Cell Biol 27 2007 147 156
45. M. Shiota, H. Izumi, A. Tanimoto, M. Takahashi, N. Miyamoto, E. Kashiwagi, A. Kidani, G. Hirano, D. Masubuchi, Y. Fukunaka, Y. Yasuniwa, S. Naito, S. Nishizawa, Y. Sasaguri, and K. Kohno Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth Cancer Res 69 2009 3148 3156
46. C. Chen, E.R. Hyytinen, X. Sun, H.J. Helin, P.A. Koivisto, H.F. Frierson Jr., R.L. Vessella, and J.T. Dong Deletion, mutation, and loss of expression of KLF6 in human prostate cancer Am J Pathol 162 2003 1349 1354
47. I. Cima, R. Schiess, P. Wild, M. Kaelin, P. Schuffler, V. Lange, P. Picotti, R. Ossola, A. Templeton, O. Schubert, T. Fuchs, T. Leippold, S. Wyler, J. Zehetner, W. Jochum, J. Buhmann, T. Cerny, H. Moch, S. Gillessen, R. Aebersold, and W. Krek Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer Proc Natl Acad Sci U S A 108 2011 3342 3347